Pradaxa Lawsuit Updates
Documents Show Pradaxa Bleeding Risks Concealed from FDA
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Documents Show Pradaxa Bleeding Risks Concealed from FDA

By Jessica Tyner

 

Pradaxa Bleeding LawsuitAs the Pradaxa class action lawsuit moves forward, new documents showcase that Boehringer Ingelheim purposefully concealed the true bleeding risks from the Food and Drug Administration (FDA). The popular anti-coagulant was marketed as a new, better option for those who need blood thinners (most often to prevent strokes). Previously, Warfarin or Coumadin was the only drug for this purpose, but it demanded a change in diet and lifestyle. Pradaxa didn’t, but then Pradaxa lawsuits started coming. As lawsuits kept coming, it was revealed that there was a chance of excessive bleeding and even death from “bleed outs.” There was no antidote to this.

New documents in the Pradaxa litigation reveal that the makers weren’t forthcoming when revealing the Pradaxa side effects to the FDA. Boehringer Ingelheim is facing hundreds of Pradaxa victims and their heirs, all claiming that the company unnecessarily put lives on the line. Currently, there are over 2,000 Pradaxa complaints, with some heirs saying their loved ones blood to death from the drug.

Read more: Documents Show Pradaxa Bleeding Risks Concealed from FDA

 
Survivor of Pradaxa Bleeding Event Files Lawsuit
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Survivor of Pradaxa Bleeding Event Files Lawsuit

By Jessica Tyner

 

Pradaxa LawsuitWarfarin, also known as Coumadin, was the go-to source for blood thinning for decades because it was the only option. It was effective, but came with some complications. For example, it could cause excessive bleeding, but doctors had an antidote on hand in case that happened. It could also be cumbersome because it required close medical monitoring and lifestyle changes.

Once Boehringer Ingelheim Pharmaceuticals introduced Pradaxa to the market, however, that was supposed to be in the past. The new blood thinner was touted as just as safe, more effective, and easier to use as there were no lifestyle changes or medical monitoring required. However, soon after this new drug was available, Pradaxa complaints started to roll in.

Read more: Survivor of Pradaxa Bleeding Event Files Lawsuit

 
Husband's Wrongful Death Lawsuit Cites Pradaxa Side Effects
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Husband's Wrongful Death Lawsuit Cites Pradaxa Side Effects

By John Curran

 

Pradaxa bleeding death lawsuitThe blood thinner Pradaxa has been linked to bleeding problems and Henry Parnell says his wife Wilma Parnell died from Pradaxa internal hemorrhaging side effects. Like many lawsuits against the German drug maker Boehringer Ingelheim, Henry says Wilma would not have taken the medication had she known of the risks.

That is a common complaint among many of the Pradaxa lawsuits now being centralized in multidistrict litigation in the Southern District Court of Illinois. Not all cases involve a wrongful death claim, however. Hundreds of people have died as a result of Pradaxa internal bleeding injuries. It is unclear where Ms. Parnell's bleeding occurred, however, it is likely that the Pradaxa internal hemorrhaging side effects came from treatment for atrial fibrillation, the most common indication.

Read more: Husband's Wrongful Death Lawsuit Cites Pradaxa Side Effects

 
Pradaxa Bleeding May be Fatal - Leads to Lawsuits
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

Pradaxa Bleeding May be Fatal - Leads to Lawsuits

By Anne Bucher

 

Pradaxa bleeding lawsuitPradaxa (dabigatran etexilate) is a prescription blood-thinning medication that is used to reduce the risk of blood clots and strokes. Pradaxa was initially approved by the U.S. Food & Drug Administration (FDA) in 2010 to prevent strokes in patients with atrial fibrillation. It was a welcome alternative to the drug warfarin, which previously had been the drug of choice for patients with atrial fibrillation. Because Pradaxa requires less ongoing monitoring than warfarin, many doctors and patients preferred the convenience offered by Pradaxa.

Patients Complain of Pradaxa Bleeding Risks

As the popularity of Pradaxa increased, so did the number of reported injuries. The most common side effect of Pradaxa is bleeding. Pradaxa bleeding affects more than 10 percent of patients who take the drug. While the Pradaxa bleeding risk is similar to that of warfarin, warfarin bleeding can be reversed with vitamin K. Because there is currently no antidote to reverse Pradaxa bleeding, many physicians are concerned about the risk of death.

Read more: Pradaxa Bleeding May be Fatal - Leads to Lawsuits

 
More than 800 Pradaxa Lawsuits Consolidated in MDL
Follow us on Twitter and Facebook for the latest Pradaxa Class Action Lawsuit & Settlement News!

 

More than 800 Pradaxa Lawsuits Consolidated in MDL

By Anne Bucher

 

Pradaxa bleeding problemsPradaxa, manufactured by Boehringer Ingelheim, is a blood thinning medication used by patients with atrial fibrillation to reduce the risk of blood clots and stroke. Pradaxa was initially approved by the U.S. Food & Drug Administration (FDA) in 2010. After its approval, it was immediately accepted as a more convenient alternative to warfarin because it required less medical monitoring than warfarin, an anticoagulant that was approved by the FDA in 1954. Warfarin required regular blood testing to ensure patients were receiving the proper dosage.

After Pradaxa was approved by the FDA, sales immediately skyrocketed. Boehringer Ingelheim reported nearly $1.5 billion in sales since 2011. However, the drug has recently been linked to significant Pradaxa health complications, including excessive bleeding. Unlike warfarin, Pradaxa does not have a bleeding antidote. The lack of an antidote means that Pradaxa bleeding poses a serious risk of death. The FDA has said that the agency received reports of more than 3,700 side effects and 540 deaths associated with Pradaxa in 2011.

Read more: More than 800 Pradaxa Lawsuits Consolidated in MDL

 
More Articles...